Plasmid-Mediated Quinolone Resistance

被引:9
|
作者
Jacoby, George A. [1 ]
Strahilevitz, Jacob [2 ]
Hooper, David C. [3 ]
机构
[1] Lahey Hosp & Med Ctr, Burlington, MA 01805 USA
[2] Hadassah Hebrew Univ, IL-91120 Jerusalem, Israel
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源
MICROBIOLOGY SPECTRUM | 2014年 / 2卷 / 05期
基金
美国国家卫生研究院;
关键词
D O I
10.1128/microbiolspec.PLAS-0006.2013
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Three mechanisms for plasmid-mediated quinolone resistance (PMQR) have been discovered since 1998. Plasmid genes qnrA, qnrB, qnrC, qnrD, qnrS, and qnrVC code for proteins of the pentapeptide repeat family that protects DNA gyrase and topoisomerase IV from quinolone inhibition. The qnr genes appear to have been acquired from chromosomal genes in aquatic bacteria, are usually associated with mobilizing or transposable elements on plasmids, and are often incorporated into sul1-type integrons. The second plasmid-mediated mechanism involves acetylation of quinolones with an appropriate amino nitrogen target by a variant of the common aminoglycoside acetyltransferase AAC(6')-Ib. The third mechanism is enhanced efflux produced by plasmid genes for pumps QepAB and OqxAB. PMQR has been found in clinical and environmental isolates around the world and appears to be spreading. The plasmid-mediated mechanisms provide only low-level resistance that by itself does not exceed the clinical breakpoint for susceptibility but nonetheless facilitates selection of higher-level resistance and makes infection by pathogens containing PMQR harder to treat.
引用
收藏
页数:24
相关论文
共 50 条
  • [1] Plasmid-mediated quinolone resistance
    Martinez-Martinez, Luis
    Cano, Maria Eliecer
    Rodriguez-Martinez, Jose Manuel
    Calvo, Jorge
    Pascual, Alvaro
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (05) : 685 - 711
  • [2] Plasmid-mediated quinolone resistance: an update
    Manuel Rodriguez-Martinez, Jose
    Eliecer Cano, Maria
    Velasco, Carmen
    Martinez-Martinez, Luis
    Pascual, Alvaro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2011, 17 (02) : 149 - 182
  • [3] Plasmid-mediated quinolone resistance - PMQR
    Piekarska, Katarzyna
    POSTEPY MIKROBIOLOGII, 2018, 57 (01): : 47 - 57
  • [4] Prevalence of plasmid-mediated quinolone resistance
    Jacoby, GA
    Chow, N
    Waites, KB
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) : 559 - 562
  • [5] Plasmid-mediated quinolone resistance in Australia
    Rodriguez-Martinez, Jose-Manuel
    Poirel, Laurent
    Pascual, Alvaro
    Nordmann, Patrice
    MICROBIAL DRUG RESISTANCE, 2006, 12 (02) : 99 - 102
  • [6] Mechanism of plasmid-mediated quinolone resistance
    Tran, JH
    Jacoby, GA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) : 5638 - 5642
  • [7] The worldwide emergence of plasmid-mediated quinolone resistance
    Robicsek, Ari
    Jacoby, George A.
    Hooper, David C.
    LANCET INFECTIOUS DISEASES, 2006, 6 (10): : 629 - 640
  • [8] Plasmid-mediated quinolone resistance: Two decades on
    Manuel Rodriguez-Martinez, Jose
    Machuca, Jesus
    Cano, Maria Eliecer
    Calvo, Jorge
    Martinez-Martinez, Luis
    Pascual, Alvaro
    DRUG RESISTANCE UPDATES, 2016, 29 : 13 - 29
  • [9] Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
    Strahilevitz, Jacob
    Jacoby, George A.
    Hooper, David C.
    Robicsek, Ari
    CLINICAL MICROBIOLOGY REVIEWS, 2009, 22 (04) : 664 - +
  • [10] Temporal Appearance of Plasmid-Mediated Quinolone Resistance Genes
    Jacoby, George A.
    Gacharna, Nancy
    Black, Todd A.
    Miller, George H.
    Hooper, David C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (04) : 1665 - 1666